Leptomeningeal tumor spread or immune checkpoint inhibitor-related encephalitis/(poli-)neuritis? An unsolved dilemma in a patient on pembrolizumab for a history of brain metastases from lung adenocarcinoma

Acta Neurol Belg. 2024 Jan 25. doi: 10.1007/s13760-023-02462-0. Online ahead of print.
No abstract available

Keywords: Adverse effects; Brain metastasis; Diplopia; Encephalitis; Immunotherapy; Lung cancer; Pembrolizumab; Radiotherapy; Tinnitus.